Schneider Susan 4
4 · APPLIED GENETIC TECHNOLOGIES CORP · Filed Dec 1, 2022
Insider Transaction Report
Form 4
Schneider Susan
Chief Medical Officer
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2022-11-30−180,000→ 0 totalExercise: $2.76Exp: 2031-11-08→ Common Stock (180,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2022-11-30−142,300→ 0 totalExercise: $0.40Exp: 2032-08-21→ Common Stock (142,300 underlying)
Footnotes (1)
- [F1]At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option.